From Gut to Mind: Impact of Probiotics on Depression, Anxiety, Mood, Gut Microbiota, Sleep and Stress—A Systematic Review of RCTs Authors: Monalisa Das, Nooruddin Thajuddin, Gangatharan Muralitharan, Megha Pundeer, Ramesh Ponnusamy, Ankita Mishra, Priyanka Nayak Published: 2026 ABSTRACT AbstractBackgroundProbiotic supplementation may influence mental health through the gut–brain axis, with potential effects on depression, anxiety, sleep, cognition, stress hormones, and gut microbial composition. This systematic review aimed to evaluate the effects of probiotics on psychological, physiological, and gut microbiome-related outcomes across diverse populations.SummaryA comprehensive search of PubMed, MEDLINE, PsycINFO, and ScienceDirect identified randomized controlled trials evaluating probiotic supplementation. Twenty RCTs were included, of which 15 were assessed as having a low risk of bias and five as having a high risk of bias. Commonly assessed outcomes included depression (n = 17), anxiety (n = 10), sleep quality (n = 9), stress (n = 6), cortisol (n = 7), cognitive function (n = 5), quality of life (n = 5), gut microbial composition (n = 11), and other neuroendocrine and inflammatory markers. Overall, probiotics were associated with improvements in depression, anxiety, sleep quality, mood, cognition, quality of life, and beneficial gut microbial populations, although findings for cortisol and stress-related outcomes were inconsistent.Key MessageProbiotic supplementation may provide beneficial effects on psychological well-being and gut microbial composition. However, heterogeneity among interventions, populations, outcome measures, and study quality warrants further well-designed RCTs.Keywords: Gut–brain axis, gut microbiota, depression, anxiety, psychological outcomes Introduction The activity of the gut microbiota is intricately connected to central nervous system (CNS) function. Through mechanisms such as neurogenesis, neurotransmission, microglial modulation and behavioural regulation, the gut transmits signals to the brain in both normal and stressful states. 1 The CNS communicates with gut microbiota through endocrine, neural and immune pathways, which modulate brain function, cognition and behaviour. 2 The gut microbiota also modulates the concentration of circulating serotonin, kynurenine, tryptophan and short-chain fatty acids (SCFAs). It also influences the blood–brain barrier, gut permeability and activation of peripheral immune cells. 3 The gut microbiota has been connected to age-related neurodegenerative diseases such as Alzheimer’s disease and mood disorders such as anxiety and depression through recent discoveries of the gut–brain axis, which refers to a reciprocal relationship between the gut and the brain.4–8 The potential of probiotics, which are a component of a balanced diet, for regulating brain health through the microbiota–gut–brain axis has drawn more attention.7, 9 The administration of probiotics is one of the methods of modifying a disturbed microbiome imbalance (gut microbial dysbiosis). 10 Anxiety and depression symptoms can be brought on by pro-inflammatory stimuli. Remarkably, probiotics can raise anti-inflammatory cytokine levels, lower pro-inflammatory cytokine levels and oxidative stress, and regulate the immune system to suppress inflammation.11–15 There is additional evidence that suggests that the pathophysiology of human depression may involve gut bacteria, notably the inflammatory response caused by exposure to lipopolysaccharide.16, 17 Two conflicting assertions are presented by several studies; one states that probiotic supplements have no discernible effect on anxiety symptoms, while another states that probiotics lower anxiety symptoms.18, 19 According to a different study, giving individuals with major depressive disorder (MDD) probiotic supplements for 8 weeks considerably raised their glutathione (GSH), high-sensitivity C-reactive protein (hs-CRP) and Beck Depression Inventory (BDI) levels. 20 Probiotic and vitamin D co-supplementation for 12 weeks reduced several oxidative stress and inflammatory markers in patients with schizophrenia. 21 Studies on animals have demonstrated that probiotic use may alter brain function and lessen symptoms of anxiety or depression.22–24 For example, giving Lactobacillus plantarum PS128 to mice under stress in their early lives may shorten their immobility period in the forced swimming paradigm of depression. 22 This systematic review aims to understand the effectiveness of probiotic supplementation on various measurement scales of depression, anxiety, perceived stress, mood, gut microbiota population and inflammatory markers in adults using randomised controlled trials (RCTs). Methods Search and Study Selection Two independent authors conducted a comprehensive literature search across PubMed, MEDLINE, PsycINFO and ScienceDirect databases for studies published in the last 10 years, applying the RCT filter. The authors constructed the literature search around the keywords (probiotics[MeSH Terms] OR probiotic*[Title/Abstract] OR psychobiotics[Title/Abstract]) AND(anxiety[MeSH Terms] OR depression[MeSH Terms] OR ‘anxiety disorders’[Title/Abstract] OR ‘depressive disorders’[Title/Abstract] OR stress[Title/Abstract] OR mood[Title/Abstract])AND (neurotransmitters[MeSH Terms] OR serotonin[Title/Abstract] OR GABA[Title/Abstract] OR dopamine[Title/Abstract] OR ‘brain-derived neurotrophic factor’[Title/Abstract] OR BDNF[Title/Abstract] OR ‘gut-brain axis’[Title/Abstract] OR ‘microbiota-gut-brain axis’[Title/Abstract]). A total of 227 randomised human trials were identified. Selection Criteria We included randomised human clinical trials published in the last decade. Studies that were published in languages other than English, had an age range of less than 20 years, had an intervention lasting less than 2 weeks, had a sample size of less than 20 or lacked depressive, cognitive and stress markers were all excluded. After applying the inclusion and exclusion criteria, a total of 20 studies were selected. The PRISMA flow diagram of the study search flowchart is presented in Figure 1. PRISMA Flow Diagram of Study Search and Included Studies. Risk of Bias Assessment The Cochrane Risk of Bias 2 (RoB 2) tool was used to assess the RoB in the included RCTs, as only RCTs were considered in this review. The RoB 2 tool evaluates bias across five domains and categorises studies as having a low RoB, some concerns or a high RoB. 25 Results Study Characteristics Twenty RCTs were included in the systematic review. These studies had 1,916 people in total, and their research periods ranged from 4 to 12 weeks. Various strains of probiotics have been used in each investigation (mentioned in Table 3). We used the studies that were carried out in the last 10 years. Table 1 provides comprehensive details of the included studies. Table 3.Various Probiotic Strains Included in the Study. Authors L. acidophilus L. johnsonii L. salivarius L. casei L. johnsonii L. lactis L. paracasei L. delbrueckii L. cremoris L. plantarum L. rhamnosus L. helveticus B. longum B. lactis B. bifidum B. infantis B. animalis B. breve S. thermophilus Kim et al. 26 –––––––––✓–––––––––Chahwan et al. 27 –––––––––––✓✓––––––Nikolova et al. 28 ––––––––––✓✓–––––––Reininghaus et al. 29 ✓–✓✓––✓––––––✓✓––✓–Schneider et. al. 30 ✓–––––✓✓–✓–––✓–✓–✓✓Morales-Torres et al. 31 –––––––––––✓✓––––––Martin et al. 32 ––––––––––––✓––––––Boehme et al. 33 –––____––––_✓–__––Slykerman et al. 34 ––––––––––✓––––––––Romijn et al. 35 –––––––––––✓✓––––––Sarkawi et al. 36 ✓–––––✓––––––––––––Önning et al. 37 ––––––––✓–––––––––Mutoh et al. 38 ––––––––––––––––✓–Climent et al. 39 (multi strain )–––––––––––––––––––Lan et al. 40 –––––––––––––––––✓–Kreuzer et al. 41 ✓–✓✓–✓✓––✓–––✓✓––––Fries et al. 42 ––––––––––––✓––––––Carlman et al. 43 –––––––––✓–✓✓––––––Hsu et al. 44 –––––––––✓––✓–✓–✓✓–Quero et al. 45 ––––––––––✓–✓✓––––– Various Probiotic Strains Included in the Study. Table 1.Characteristics of the Included Studies. Author Name Sample Size/Participant Details Mean Age and Male and Female Distribution Intervention Time Variable Studied Result Kim et al. 26 N = 63PG = 31 participantsPLG = 32 participants69.1 + –3.612 weeksMini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), forward and backward digital span tests, A&B trail-making tests, Test of Memory and Verbal Learning (Rey Auditory Verbal Learning), executive function tests (Ex-stroop Test), Geriatric Depression Scale (GDS), Beck Depression Inventory (BDI), State–Trait Anxiety Inventory (STAI), Profile of Mood States (PoMS), quality of life questionnaires, relative abundance of key genera Bifidobacterium, Lactobacillus, Akkermansia, Faecalibacterium, short-chain fatty acids (SCFAs), C-reactive protein (CRP), cytokines (interleukin [IL]-6, tumour necrosis factor-alpha [TNF-α], IL-10), brain-derived neurotropic factor (BDNF), cortisol, serotonin and dopamine levels, adherence to probiotic regimen, adverse events, dietary recordsThe probiotic group exhibited a significantly greater improvement in mental flexibility test scores compared to the placebo. Significant reductions in self-reported stress scores, as measured by the GDS and the Positive and Negative Affect Schedule (PANAS), showed trends but did not reach statistical significance. Gut bacteria that promote inflammation (Eubacterium and Clostridiales genera) were significantly reduced in response to serum BDNF levelsChahwan et al. 27 N = 71PG = 35PG = 3618–658 weeksBeck Depression Inventory-II (BDI-II), Leiden Index of Depression Sensitivity (LEID-R), gut microbiota composition and relative abundanceSignificant reductions in depression scores over the 8-week intervention period; a statistically significant difference in BDI-II scores was found between the probiotic and placebo groups. The Leiden depression sensitivity index has been updated. The probiotic group showed a notable decrease in cognitive reactivity among participants with mild to moderate depression. There will be notable alterations in the general population of gut microbesNikolova et al. 28 N = 50PG = 24PLG = 2518–558 weeksGeneralised Anxiety Disorder (GAD-7), the Inventory of Depressive Symptomatology (IDS) and Depression Rating Scale (HAMD-17)Greater reduction was seen on the Hamilton Depression Rating Scale (HAD-D). Reduction of CRP and IL-6 was also favourably modulatedReininghaus et al. 29 N = 82P+B = 41PL+B = 4118–754 weeksHamilton Depression Rating Scale (HAM-D), BDI-II, symptom checklist-90 (SCL-90), alpha diversity of the gut microbiota, beta diversity, specific taxa abundance, vitamin B6/B7 biosynthesisThe probiotic+biotin group shows a significant reduction in depression scores. HAM-D score and the overall psychological well-being increased in the probiotic group, as evidenced by a significant improvement in the BDI-II score and a significant decrease in SCL-90. Alpha-diversity of gut microbiota increased significantly in the probiotic group. Modification in several taxa, including Coprococcus and Ruminococcus. The pathway was upregulated in the formation of SCFAs and vitamin B biosynthesisSchneider et al. 30 N = 60PG = 30PLG = 3018–55 years4 weeksCorsi Block Tapping Test (CBTT), serum levels of BDNF, verbal learning memory test (VLMT) and functional magnetic resonance imaging (fMRI) hippocampal activation during working memoryVerbal episodic memory (VLMT), Corsi Block Tapping and elevated blood BDNF levels were all significantly improved in the probiotic group. Only the probiotic group showed increased right hippocampal activation during working memory tasksMorales-Torres et al. 31 N = 131PG = 65PLG = 6018–45 years4 weeksPittsburgh Sleep Quality Index (PSQI), Depression Anxiety Stress Scale-21 (DASS-21) and Generalised Anxiety Disorder-7 (GAD-7) self-reported questionnaires on lifestyleThere was no statistically significant reduction in GAD-7 scores when comparing the psychobiotic group to the placebo group, nor significant changes in sleep quality (PSQI) or DASS-21 in the whole sample. Participants with healthier lifestyle factors showed a significant reduction in anxiety scoresMartin et al. 32 N = 35PG = 16PLG = 1918–70 years6 weeksHospital Depression and Anxiety Scale (HADS), using fMRI, the amygdala’s response to emotional stimuli, tryptophan, bile acids, free fatty acids, butyric acid and a high concentration of Bifidobacterium longum NCC3001 faecesUsing the HADS assessment, the probiotic group’s anxiety and sadness levels significantly decreased. Reduced amygdala activation in response to distressing emotional stimuli following probiotic treatment. Levels rise when butyric acid is present. Increased the synthesis of glycine-conjugated bile acids, tryptophan and N-acetyl tryptophan. Increased B. longum faecal abundanceBoehme et al. 33 N = 45PG = 23PLG = 2225–656 weeksPerceived Stress Scale (PSS), salivary cortisol levels, gut microbiota composition, salivary cortisoneSignificant reduction in PSS scores. Cortisol and cortisone did not show statistically significant changes. Minor modulation of gut microbiota composition was observed, but no major shifts in overall diversitySlykerman et al. 34 N = 423PG = 212PLG = 211More than 18 years6 weeksEdinburgh Postnatal Depression Scale (EPDS) for postpartum depression symptoms and the State–Trait Anxiety Inventory (STAI-6) for postpartum anxiety symptoms57% reduction in odds of depression in the probiotic group38% reduction in the odds of anxiety in the probiotic groupRomijn et al. 35 N = 79PG = 39PLG = 4018–658 weeksHospital Anxiety and Depression Scale-Depression subscale (HADS-D), PSQI, LEIDS-R and CRP are used to test cognitive response to depressed moodsThere was a notable decrease in the probiotic group’s anxiety (HADS-A) and depression (HADS-D) ratings. The probiotic group showed a significant improvement in sleep quality, as shown by their PSQI scores. Reduction in cognitive reactivity, as measured by LEIDS-R scores, was significantly reduced in the probiotic group. Morning salivary cortisol levels showed reduced significant change in CRP proteinSarkawi et al. 36 N = 110,IBS = NM+Placebo = 27–28IBS-NM-probiotic–27–28IBS-SD+Placebo–27–28IBS–SD+Probiotic = 27–2818-6512 weeksCenter for Epidemiologic Studies Depression Scale-Revised (CESD-R)Brief Symptom Inventory (BSI), serotonin levels in the plasma, faecal SCFAs, acetate, propionate, butyrate and irritable bowel syndrome symptoms severity score (IBS-SSS), Bristol Stool Form Scale, faecal microbiota composition, especially changes in Lactobacillus and BifidobacteriumThe probiotic group’s depression scores (CESD-R) were considerably lower than those of the placebo group. The probiotic group showed a considerable increase in plasma serotonin. Improvement is seen in IBS-SSS, although there are no appreciable differences between the probiotic and placebo groups. Rise in the probiotic group’s butyrate and propionate levels. Lactobacillus species are more prevalent in the probiotic categoryÖnning et al. 37 N = 127PG = 63PLG = 6425–5012 weeksEpisodic memory, working memory, speed of attention, accuracy of attention, PSS-14, Korolinska Sleep Questionnaire (KSQ), Hospital Depression and Anxiety Scale (HADS)The probiotic group showed significant improvement in episodic memory, working memory, speed and accuracy of attention. PSS-14 scores significantly decreased, and HADS scores showed no significant changes. Sleep quality improved significantlyMutoh et al. 38 N = 76PG = 38PLG = 3820–646 weeksHRV at rest during mental stress, cerebral blood flow changes using near-infrared spectroscopy (NIRS), gut microbiota composition by stool analysis, mood states (PoMS) questionnaire, PSQIThe Bifidobacterium breve -M-16v group slowed the increase in parasympathetic activity and reduced sympathetic activity compared to placebo. Participants in the probiotic group exhibited lower prefrontal cortex activation during stress, indicating a reduced mental load. The probiotic group showed a significant increase in Bifidobacterium abundance. Improvement in PoMS mood scores and sleep quality (PSQI) was observed in the probiotic group compared to the placeboCliment et al. 39 N = 105P+NS4 = 53PLG = 5218–7012 weeksThe STAI, the BDI-II, sleep quality (PSQI), cognitive function (MoCA), serum tryptophan, serum cortisol, CRP, IL-6, BDNF, gut microbial compositionIn contrast to the other two groups, the SU-PR group’s BDNF levels dropped. The SU-PR group’s SF12-MH ratings significantly increased, indicating improved mental quality of life, whereas their HADS-D scores significantly decreased, showing depressed symptoms. Increased Barnesiella and decreased Acidaminococcus and Akkermansia abundanceLan et al. 40 N = 40PG = 20PLG = 204 weeksPSQI, cortisol levels, adrenocorticotropic hormone (ACTH) levels, serum serotonin, gut microbiota compositionPSQI total score significantly decreased in the probiotic group compared to the placebo group. Serum serotonin significantly increased in the probiotic group. The relative abundance of Bifidobacterium and Lactobacillus increased, while potentially harmful bacteria Escherichia coli and ShigellaKreuzer et al. 41 N = 47PG+Vitamin B7 = 23PLG = 2418–754 weeksClock gene expression (BMAL1, CLOCK, PERI, PER2, CRY1, CRY2) in peripheral blood mononuclear cells (PBMCs), Hamilton Depression Rating Scale (HDRs), vitamin B7/biotin, SCFAs, gut microbial composition, inflammatory markers like IL-6, TNF-α, CRPSignificantly improved depressive symptoms, Increased expression of certain clock genes in PBMCsFries et al. 42 N = 189PG = 93PLG = 9620-408 weeksSTAI, EPDS and B. longum detectionOverall, EPDS depression levels did not differ statistically significantly between probiotics and placeboThere was no discernible decrease in anxiety symptoms (lower STAI scores)Carlman et al. 43 N = 56PG = 28PLG = 2820–404 weeksBrain responses to stress assessed by fMRI during an arithmetic stress task, salivary cortisol levels, STAI scores, gut microbial compositionDuring times of stress, probiotic supplementation altered patterns of brain activity in regions linked to emotional regulation and cognitive control. Salivary cortisol responses to the math stress task were lower in the probiotic group than in the placebo group, and their state anxiety levels were significantly lowerHsu et al. 44 N = 100PG = 50PLG = 5060–9012 weeksIL-1β, TNF-α, IL-6, malondialdehyde (MDA), total antioxidant capacity (TAC), superoxide dismutase (SOD) activity, glutathione peroxidase (GPx) activity, MMSE, MoCAThe probiotic group showed a significant improvement in MMSE and MoCA scores compared to the active control group after 12 weeks. Serum BDNF increased significantly in the probiotic group compared to the control, with a significant reduction in IL-1β and TNF-α in the probiotic group. IL-6 showed a decreasing trend, but it was not statistically significant. Significant decrease in MDA levels in the probiotic group. Significant increase in TAC, SoD and GPx activation compared to controlQuero et al. 45 N = 27PG = 14PLG = 1318–3530 daysOverall well-being, degree of stress, anxiety, exhaustion, depression, the quality of sleep, IL-1β, IL-10, immunoglobulin A (IgA), dopamine, serotonin, epinephrine, norepinephrine, corticotropin-releasing hormone (CRH), ACTH and cortisolSignificant improvement in perceived general health, Significant reduction in stress and anxiety, and improved sleep quality in professional soccer players; significant subjective improvement in sedentary individuals. Athletes do not have any significant changes in IL-1β, IL-10 and SIgA. In sedentary males, IL-1β increased significantly, and IL-10 and SIgA concentrations did not change Characteristics of the Included Studies. Methodological Quality (Risk of Bias) Among the 20 included RCTs, 5 studies were rated as having a high RoB, indicating a moderate to great overall concern. The remaining 15 studies were judged to have a low RoB. The detailed RoB is presented in Figure 2. Methodological Quality Assessment for Randomised Controlled Trials (RCTs). Source: Risk-of-Bias (RoB) tool. Effects of Probiotics on Different Populations Healthy Population Among the 20 studies reviewed, 10 focused on the effects of probiotics in healthy populations.26,31,33,34,37,38,40,42,43,45 The above study encompasses various depression rating scales, anxiety measuring scales, stress scales, sleep quality measuring scales, mood measuring scales, cognition, quality of life, stress hormones, neurotransmitters, inflammatory markers, gut microbial compositions and brain responses as measured by functional magnetic resonance imaging (fMRI). The details of biological markers measured in this systematic review are mentioned in Table 2. The duration of intervention across all studies ranged from 4 to 12 weeks, with each survey including a placebo-controlled group. This systematic review mostly includes various strains of Lactobacillus and Bifidobacterium, and the detailed probiotic strains are mentioned in Table 3. Table 2.Various Biomarkers Included. Authors Anxiety, Stress, Mood and Depression Scales Sleep Index Scales Stress Hormones and Neurotransmitters Inflammatory Markers and Anti-inflammatory Markers Gut Microbial Population and Their Metabolites fMRI HDRS or HAM-D or HAMD-17 STAI or STAI-6 LEID-R GAD-7 BDI-II or BDI SLC-90 VLMT DASS-21 PSS or PSS-14 EPDS MoCA MMSE CESD-R IDS PoMS PSQI KSQ BDNF Cortisol Serotonin ACTH Dopamine Epinephrine C-reactive Protein IL-6 TNF-α IL-1β IL-10 IgA Faecal Gut Microbiota Population SCFAs Vitamin B6/B7 Amygdala Reactivity to Emotional Stimuli Kim et al. 26 –✓––––––––✓✓–✓––✓✓✓–✓–✓✓✓–✓–✓✓––Chahwan et al. 27 –✓✓–✓–––––––––––––––––––––––✓–––Nikolova et al. 28 ✓✓–✓–––––––––✓–––––––––––––––––––Reininghaus et al. 29 ✓✓––✓✓–––––––––––––––––––––––✓–✓–Schneider et al. 30 ✓–––––✓––––––––––✓––––––––––––––✓Morales-Torres et al. 31 –✓–––––✓–––––––✓–––––––––––––––––Martin et al. 32 ✓––––––––––––––––––––––––––––✓––✓Boehme et al. 33 ✓–––––––✓–––––––––✓––––––––––✓–––Slykerman et al. 34 ✓✓✓––––––✓–––––––––––––––––––––––Romijn et al. 35 ✓–✓––––––––––––✓–––––––✓–––––––––Sarkawi et al. 36 ––––––––––––✓––––––✓–––––––––✓✓––Önning et al. 37 ––––––––✓–––––––✓––––––––––––––––Mutoh et al. 38 ––––––––––––––✓✓–––––––––––––✓–––Climent et al. 39 ✓–––––––––✓––––✓–✓✓––––✓✓––––✓–––Lan et al. 40 –––––––––––––––✓––✓✓✓––––––––✓–––Kreuzer et al. 41 –––––––––––––––––––––––✓✓✓–––✓✓✓Fries et al. 42 –✓–––––––✓–––––––––––––––––––✓–––Carlman et al. 43 ––––––––––––––––––✓––––––––––✓––✓Hsu et al. 44 ––––––––––✓✓–––––––––––––✓✓––––––Quero et al. 45 ––✓✓✓––✓✓✓✓✓ Various Biomarkers Included. Healthy Athlete Group (Including Soccer Players): Quero et al. 45 conducted a triple-blind, randomised, placebo-controlled pilot trial in professional soccer players and sedentary students over 4 weeks. Participants received either a symbiotic supplement or a placebo. Results showed reduced cortisol and inflammation in athletes, while sedentary individuals had improved immune parameters. The study suggests that physical activity status influences symbiotic effects. 45 Healthy Pregnant Women: Slykerman et al. 34 performed a study in 380 pregnant women in New Zealand. Participants received Lactobacillus rhamnosus HN001 or a placebo from mid-pregnancy to 6 months postpartum. The probiotic group showed significantly lower postpartum depression and anxiety scores. This suggests that HN001 may help prevent maternal mood disorders. 34 Another study mentioned that Bifidobacterium longum supplementation reduces anxiety and depression during the perinatal period. 42 Diseased Population Depressed Population: Out of the twenty studies, six were conducted specifically in participants with MDD or depressed populations. The remaining studies focused on other populations, such as healthy adults, pregnant women, older adults, athletes or patients with medical conditions.27–30,35,41 The details of the study are provided in Tables 1 and 2. Patients with Inflammatory Bowel Disease: Out of the 20 RCTs, only two were conducted in participants with irritable bowel syndrome (IBS).32, 36 Martin et al. 32 conducted an RCT in IBS patients with psychological comorbidities. Probiotic supplementation led to improvements in anxiety and depression symptoms, along with beneficial metabolomic changes. 32 Another RCT was performed in patients with IBS and depression. Participants who received a Lactobacillus-containing cultured milk drink showed significant improvement in depressive symptoms compared with the placebo. 36 Patients with Chronic Kidney Disease: Climent et al. 39 carried out a randomised trial in haemodialysis patients receiving nutritional supplements with probiotics. The intervention improved psychological well-being and offered protective benefits compared to a placebo. 39 Patients with Alzheimer’s Dementia: Hsu et al. 44 conducted a 12-week study in patients with Alzheimer’s dementia. Probiotic supplementation improved cognitive function and was associated with favourable changes in BDNF levels, inflammation and oxidative stress biomarkers compared to controls. 44 Effects of Probiotic Supplementation on Various Biological Markers Various Depression Rating Scales Depression has drastically increased in recent years, and in this systematic review, we included 19 studies that used various depression measuring scales, including Hamilton Depression Rating Scale (HAM-D17/HAM-D), Geriatric Depression Scale (GDS), Montgomery–Åsberg Depression Rating Scale (MADRS), Edinburgh Postnatal Depression Scale (EPDS), Beck Depression Inventory-II (BDI-II) and Center for Epidemiologic Studies Depression Scale-Revised (CESD-R). Hamilton Depression Rating Scale-Depression: The HAM-D17 or HDR is now one of the most popular measures for assessing the intensity of depressive symptoms and evaluating the effectiveness of treatment. 46 This systematic review included 20 RCTs, out of which 9 measured the HAM-D17 scale (n = 9). A significant reduction was observed in the probiotic group.28, 29, 32, 39 A few studies did not have a significant difference in the probiotic group.30, 33, 35 Both groups had low baseline scores. 34 Geriatric Depression Scale: One of the most popular depression self-reports available today is the GDS. Only one study included this scale (n = 1). The probiotic group showed reduced depressive symptoms. 26 Montgomery–Åsberg Depression Rating Scale: MADRS is the world’s most extensively used depression scale in clinical and psychopharmacological depression research. 47 Only two studies included this scale (n = 2). The probiotic group experienced a significant decrease in MADRS values. 27 Both the probiotic and placebo groups showed a reduction in scores. 35 Edinburgh Postnatal Depression Scale: The primary purpose of the EPDS is to identify depression in expectant and postpartum women. 48 Only two studies (n = 2) have been included in this scale. The probiotic group had lower depression scores.34, 42 Beck Depression Inventory-II: The BDI is one of the most widely used tools for measuring depressive symptoms globally. 49 Two studies measured this scale (n = 2). No significant changes were observed in the probiotic group. 27 BDI-II scores were reduced in the probiotic group. 29 Center for Epidemiologic Studies Depression Scale: It is another scale used to measure depression. 50 Only one study included this scale (n = 1) to measure depression. There was a significant reduction in the depression score in the probiotic group. 36 Various Anxiety Rating Scales Anxiety and depressive disorders affect around 10% of the global population. In this systematic review, 10 studies assessed anxiety symptoms using various standardised scales, including State–Trait Anxiety Inventory (STAI) and Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A). State–Trait Anxiety Inventory Scale (STAI or STAI-6): STAI-S is the most commonly used anxiety scale to measure the level of anxiety. 51 Out of 20 RCTs, 8 studies have measured STAI-S (n = 7). The study did not find any changes in the probiotic group. 28 Most of the studies had significantly lower anxiety scores at postpartum compared with placebo.26,27,29,31,34,42 Hospital Anxiety and Depression Scale-Anxiety Subscale: HADS-A is another anxiety measurement scale that measures the level of anxiety. Three studies have included this scale (n = 3). Significant improvement in the HADS-A scale in the probiotic group.32, 33 No significant changes were observed in the probiotic group. 35 Generalised Anxiety Disorder-7: GAD-7 is a brief, validated, self-reported questionnaire used to screen for and measure the severity of GAD symptoms. Only one of the studies mentions that GAD-7 scores (n = 1) also trended lower in the probiotic group, but the differences were not statistically significant at week 4. 28 Primary Tools Used to Measure Stress Scale In this systematic review, 10 studies assessed anxiety symptoms using various standardised scales, including the Montreal Imaging Stress Task (MIST) and the Perceived Stress Scale (PSS). Montreal Imaging Stress Task: MIST is a mental erythrometric task used to analyse mental performance. 52 Only one study has included (n = 1) this study. No significant changes will be observed in the probiotic group. 43 The Perceived Stress Scale (PSS-14/PSS): A self-report tool called PSS was created to measure the extent to which respondents thought their lives were disorganised, beyond control and overloaded. 53 Five studies have included this study (n = 5). A significant reduction will be observed in the probiotic supplementation group.27, 33 No significant difference will be observed between the two groups.35, 37 Decreased PSS-14 scores in the probiotic group compared to the placebo group. 34 Sleep Quality Sleep quality was primarily assessed using the Pittsburgh Sleep Quality Index (PSQI), a widely used standardised tool. Pittsburgh Sleep Quality Index: Neurocognitive dysfunctions, such as poor impulse control, depression, anxiety, stress and attention deficiencies, are associated with sleep disturbances. In clinical and research contexts, the PSQI plays a significant role in evaluating sleep health. Nine studies have included this scale (n = 9), and most of the studies have shown improvement in sleep quality. Sleep quality will improve in the probiotic group.33,34,37,38,40,45 No significant difference between the probiotic and placebo groups. 35 Moods The Profile of Mood States: The Profile of Mood States (PoMS) was originally developed to measure mood and feeling states of psychiatric outpatients. 54 Three studies measured this scale (n = 3), and all studies have mentioned that there is an improvement in the PoMS scale. Significant improvement was observed in all subscales in the probiotic group.27, 37, 38 Visual Analogue Scale: The Visual Analogue Scale (VAS) is a self-report measurement tool often used in clinical and psychological research to capture subjective experiences, such as pain, mood, anxiety, stress or well-being. 55 Only two studies have measured these scales (n = 2). Improvement in perceived well-being in the probiotic group. 45 VAS score is lower in the probiotic group. 34 Positive and Negative Affect Schedule: The Positive and Negative Affect Schedule (PANAS) is a self-report questionnaire used to measure mood and emotions. 56 The positive PANAS change score was higher in the placebo group. 34 A significant reduction was observed in PANAS score. 31 Psychological Well-being Ryff Well-being Scale: The Ryff Well-being Scale (RYFF) is mainly used to measure overall psychological well-being. 57 Only one study (n = 1) has been included, but it does not show any changes that will be observed. 31 Cognitive Functions Ageing may bring about mild cognitive changes; however, substantial cognitive decline is typically a sign of pathological ageing. In this systematic review, five studies (n = 5) have measured the various cognitive parameters and showed mixed types of responses after probiotic interventions. Two studies showed trends of improvement in cognitive functions in the probiotic group compared to the placebo group.37, 44 Another two studies mentioned that there is an improvement in memory and attention in the probiotic group.26, 37 No significant changes in memory, attention or executive function were observed over the intervention period in the probiotic group. 28 Significant improvement was observed in attention, processing speed and executive function in the probiotic group compared to the placebo. Memory performance showed trends towards improvement. 30 Quality of Life (SF12-MH Scale, SF-36) SF-36/SF12-MH is a widely used health survey, a validated questionnaire designed to measure health-related questions about quality of life. 58 Five studies have measured quality of life, giving mixed type of responses. Significant improvement in quality of life was observed compared to the placebo.29, 36, 39 No notable changes were observed.31, 35 Stress Hormones and Neurotransmitters Serum Serotonin Levels: Only one study has measured serotonin concentration (n = 1). Serum serotonin levels significantly increased in the probiotic group. 36 Cortisol Concentration. Cortisol is a major stress hormone; a total of seven studies have included (n = 7), showing mixed responses. Significant reduction of cortisol concentration was observed in the probiotic group.37, 40, 42, 45 No significant changes were observed in cortisol concentration in the probiotic group.34, 36, 43 Adrenocorticotropic Hormone: Adrenocorticotropic hormone (ACTH) is another symbol of stress associated with psychological imbalance. Two studies have included ACTH (n = 2). Both studies show a significant reduction of ACTH concentrations in the probiotic group.40, 42 Brain-derived Neurotrophic Factor. Brain-derived neurotrophic factor (BDNF) plays a crucial role in learning, memory, mood regulation and neuroplasticity. 59 Only three studies have measured serum BDNF concentrations (n = 3). The probiotic group and the placebo group did not show any changes in BDNF levels. 39 Serum BDNF concentration increased.30, 44 Inflammatory Markers Depression is associated with increased levels of inflammatory markers such as CRP, interleukin (IL)-2 receptors, IL-6, IL-1 and tumour necrosis factor-alpha (TNF-α).60, 61 Only four studies have included inflammatory markers, and most have reported a significant decrease in these markers. Interleukin-1β: IL-1β is a proinflammatory cytokine that mediates immune cell activation, inflammatory signalling and innate and adaptive immunity. Only one study has measured the concentration of IL-1β; levels decreased significantly in the probiotic group. 44 C-reactive Protein: CRP is a marker of inflammation; in this systematic review, only two studies have measured the concentration of CRP. When compared to the placebo group, CRP levels dramatically dropped in the probiotic group. 45 No significant changes were observed in CRP concentration in the probiotic concentration. 28 Interleukin-6: IL-6 is the most important inflammatory marker, and in this systematic review, only two studies have measured the concentration of IL-6. IL-6 levels decreased significantly in the probiotic group.27, 45 Immunoglobulin A: Immunoglobulin A (IgA) provides mucosal immunity by neutralising pathogens. Only one study has measured the concentration of IgA. IgA concentration increased significantly in the probiotic group. 45 Tumour Necrosis Factor-alpha: Only one study has measured significant changes in TNF-α levels in the probiotic group. 27 Gut Microbiota Composition Microbiota-mediated tryptophan metabolism, microbial regulation of neuroimmune signalling, microbial generation of neuroactive chemicals, vagus nerves and microbial control of neuroendocrine activities are some of the ways in which gut microbiota may affect the brain and mental health.62, 63 A total of 11 studies have measured the gut microbial composition (n = 11). Akkermansia and Acidaminococeae composition is decreased in the probiotic group, and Barnesiella population is increased in the probiotic group. 39 Increased Bifidobacterium abundance. 42 Increased beneficial bacteria species. 43 An increase in beneficial bacterial species, such as Bifidobacterium and Lactobacillus, was observed after symbiotic supplementation. 45 Increased abundance of beneficial bacteria, including Bifidobacterium and Lactobacillus species.26, 27, 29 Moderate changes in gut bacterial composition in the probiotic group. 28 B. longum levels were higher in the probiotic group than in the placebo group.32–34 Short-chain Fatty Acids G-protein-coupled receptors allow SCFAs to have a major impact on emotional states and recognition. 64 Only one study has measured SCFA concentrations. Increased the plasma level of butyric acid. 32 Brain Responses Measured by Functional Magnetic Resonance Imaging During the arithmetic stress exercise, the probiotic group displayed neuronal activity in areas linked to stress processing, such as the prefrontal cortex and amygdala. 43 Decreased amygdala activation to negative emotional stimuli was observed after probiotic treatment. 32 Discussion Most studies have shown a reduction in depression and anxiety scales, improved sleep quality, enhanced mood states, improved cognitive functions, improved quality of life and a beneficial gut microbiota population in the probiotic group. Around 11 studies have measured the gut microbial population, and most of the studies have shown an increase in beneficial bacterial species, such as Bifidobacterium and Lactobacillus. Probiotics such as Bifidobacterium and Lactobacillus are thought to have positive impacts on both mental and physical health, including psychiatric symptoms. Healthy volunteers who take probiotic supplements of B. longum and L. helveticus report fewer symptoms of discomfort and lower levels of free cortisol. 65 Human probiotic supplementation is therefore thought to have the ability to improve the gastrointestinal (GI) tract’s bacterial composition and, consequently, behaviour and mental health.66, 67 According to new research, probiotics may significantly affect several brain processes via regulating the gut–brain axis. When Rudzki et al. looked at the benefits of L. plantarum probiotics as an adjunct therapy for cognitive functioning in individuals with MDD, they discovered that the probiotic group had better instantaneous verbal memory recall than the placebo group. 68 Important interactions between probiotics and the brain may be explained by the hypothalamic–pituitary–adrenal axis (HPA axis) and inflammatory pathways. Probiotic use altered the HPA axis’s hyperactivity. 69 In rats, treatment with Lactobacillus farciminis or ML-7 decreased endotoxaemia, inhibited the activation of the HPA axis and reduced inflammation in the brain. 11 The afferent and efferent branches of the vagus nerve are essential for two-way communication between the gut and the brain. It may have a role in conditions such as depression by using its afferent fibres to pick up signals from the gut microbiota and send them to the brain. Through vagal efferents, stress-induced brain alterations might exacerbate depression by increasing intestinal permeability and inflammation. Vagus nerve stimulation has been used to treat depression and has anti-inflammatory properties. However, decreased vagal tone is frequently associated with depression, which may be exacerbated by stress. 70 Following a subdiaphragmatic vagotomy, the three bacterial strains or FMT from Chrna7 mutant mice did not produce behavioural issues, body inflammation or loss of synaptic proteins in the prefrontal cortex.71–73L. rhamnosus probiotic supplementation can lower stress-induced corticosterone and anxiety, although vagotomised mice did not exhibit behavioural alterations associated with depression. 74 The communication between the stomach and brain may be influenced by SCFAs, which are created by gut microorganisms through the metabolism of indigestible fibres. By promoting T-cell differentiation, regulating the synthesis of inflammatory cytokines and affecting the creation of serotonin and other neurotransmitters, SCFAs have positive effects on mental health and inflammation. By changing inflammation and neurotransmitter balance, which can affect mood regulation, SCFAs may exacerbate depression. 75 In mice under chronic stress, SCFA administration reduced depressed and anxious behaviour. 76 Gut microbiota may affect the metabolism of tryptophan. 77 Tryptophan is the precursor for 5-HT (serotonin) synthesis by EC cells in the gut and neurons in the enteric system and CNS. 78 Serotonin plays a central role in regulating sleep. Serotonergic signalling influences behavioural states and interacts with brain regions that control the circadian rhythm. 79 Gamma-aminobutyric acid (GABA) plays a key role in regulating anxiety; brain imaging studies have demonstrated reduced benzodiazepine receptor binding on GABA receptors in individuals with anxiety disorders, along with decreased cortical GABA levels as measured by magnetic resonance spectroscopy (MRS).80–84 In addition, microbes produce gamma-aminobutyric acid in vitro, but the effectiveness varied among different species. 85 This systematic review is unique in several aspects, as it is the first to comprehensively evaluate probiotic supple–mentation involving various strains of Bifidobacterium, Lactobacillus and S. thermophilus. The review encompasses studies published over the last 10 years and includes an analysis of various measurement scales of depression, anxiety, perceived stress, mood, sleep quality, quality of life, gut microbiota population and inflammatory markers. All the studies included in the review adhered to a uniform design, comprising an experimental group administered probiotics and a placebo-controlled group. Another RCT mentioned that the probiotic capsule consisted of various strains of Bifidobacterium and Lactobacillus, which had beneficial effects on depressive symptoms and glucose metabolism. 21 Limitations There are certain restrictions on the current systematic review. First, the validity and generalisability of the findings may be impacted by the included research’s inconsistent sample sizes and demographic distributions. The inclusion of diverse population groups and various strains of Bifidobacterium and Lactobacillus contributes to the complexity of this study. Additionally, variations in disease conditions and intervention durations may have influenced the outcomes related to various biological markers. Given the heterogeneity among the included studies, the findings of this systematic review should be interpreted with caution. Furthermore, the limited use of standardised outcome measures across studies poses challenges for data pooling and restricts the robustness of analytical evaluations. Conclusion Most studies have shown a reduction in depression and anxiety scales, improved sleep quality, enhanced mood states, enhanced cognitive functions, improved quality of life and a beneficial gut microbiota population in the probiotic group. Cortisol and various stress scales have mixed responses. The concentration of BDNF will remain unchanged, and proinflammatory cytokines are difficult to measure because of their low sample size. Current evidence suggests that probiotic supplementation improves depressive scales, anxiety scales, sleep index, gut microbial composition, quality of life, cognitive functions and various mood states. Acknowledgement The authors are grateful to the Bharathidasan University’s Department of Microbiology in Tiruchirapalli, India. The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article. Funding: The authors received no financial support for the research, authorship and/or publication of this article. ORCID iD: Gangatharan Muralitharan https://orcid.org/0000-0001-9452-3053 Authors’ Contribution Monalisa Das: Writing the original draft, investigation, methodology. Nooruddin Thajuddin: Conceptualization, supervision. Gangatharan Muralitharan: Conceptualization, supervision, & formal analysis. Megha Pundeer: Software, methodology. Ramesh Ponnusamy: Writing - review. Ankita Mishra: Software, methodology. Priyanka Nayak: Investigation. Statement of Ethics Since the article is a systematic review, ethical considerations might not be necessary. References